Product Description:

Faslodex (Fulvestrant) injection is a powerful and effective medication prescribed to treat certain types of hormone receptor-positive breast cancer. It is a form of hormone therapy, which works by blocking the action of the hormone estrogen in the body, thus slowing the growth of the cancer cells. Faslodex is available in a 500mg/5ml strength and is administered intramuscularly once every 28 days. It is important to note that neither Faslodex nor any medication containing fulvestrant should be used by pregnant or breastfeeding women. The shelf life of Faslodex is 36 months.

Features:

• Product Name: Faslodex Injection
• Strength: 500mg/5ml
• Active Ingredient: Fulvestrant
• Dosage: 250mg Intramuscularly Once Every 28 Days
• Country of Origin: India
• Faslodex Injection 500mg
• Faslodex
• Faslodex Injection 500 mg
• Fulvestrant 500 mg Injection

Technical Parameters:

Applications:

Fulvestrant Injection, manufactured by Pfizer, is a powerful medication designed to treat postmenopausal women with hormone receptor-positive, advanced or metastatic breast cancer. The active ingredient, fulvestrant, is a steroidal estrogen receptor antagonist that binds to estrogen receptors and blocks the effects of estrogen in the body. Strength and efficacy are achieved through the 500mg/5ml dosage, which is administered intramuscularly once every 28 days.

The drug is known for its potency and effectiveness. It is effective in treating advanced or metastatic breast cancer in postmenopausal women. Additionally, Fulvestrant Injection can help reduce the risk of breast cancer recurrence and progression. Patients should store the medication at room temperature and follow the dosage instructions carefully. Women who are pregnant or breastfeeding should not use this medication.

Faslodex Injection, manufactured by Pfizer, is a powerful medication with numerous benefits. Its strength and efficacy are achieved through the 500mg/5ml dosage, which is administered intramuscularly once every 28 days. This medication can help reduce the risk of breast cancer recurrence and progression in postmenopausal women. Additionally, it is important for patients to store the medication at room temperature and follow the dosage instructions carefully. Women who are pregnant or breastfeeding should not use this medication.

Support and Services:

Fulvestrant provides technical support and services to ensure the best possible user experience. Our technical support team is available 24/7 to answer any questions you may have about the product. We also offer online tutorials and manuals to help you get started with the product quickly and easily. Additionally, we offer regular software and firmware updates to keep your Fulvestrant product up-to-date and running smoothly. We also provide customer service for any other product-related questions or issues.

FAQ:

• Q: What is Fulvestrant?
  A:Fulvestrant is a prescription medicine used to treat a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer in postmenopausal women.
• Q: What are the benefits of Fulvestrant?
  A:Fulvestrant may help slow the growth of cancer cells and help improve the length of time until the cancer spreads.
• Q: Who should take Fulvestrant?
  A:Fulvestrant is for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
• Q: How is Fulvestrant taken?
  A:Fulvestrant is given as two injections into the muscle of the buttocks. It is usually given once a month for 3 months, then once every 2 months.
• Q: Are there any potential side effects?
  A:Fulvestrant may cause side effects, such as injection site reactions, nausea, tiredness, hot flashes, headache, and muscle or joint pain.